10.1016/S0140-6736(24)02317-1 [DOI] [PMC free article] [PubMed] 2.Ghusn W, Hurtado MD (2024) Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Recently, glucagon-like peptide 1 receptor agonists (GLP-1RAs), a class of drugs used to treat type 2 diabetes and obesity, have shown therapeutic effects against NAFLD
Nat Commun (2026)
This is a class effect shared across all GLP-1 receptor agonists , not a flaw in any particular medication
Codeage GLP-Advantage+ supplement is a comprehensive blend of chromium, berberine HCl, decaffeinated green tea, gymnema sylvestre, curcumin, L-taurine, resveratrol, boron, and a probiotic blend including akkermansia muciniphila